Cue Health Analyst Ratings
Cue Health Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 59.74% | Goldman Sachs | $0.75 → $0.5 | Maintains | Neutral |
| 06/05/2023 | 139.62% | Goldman Sachs | $2.75 → $0.75 | Maintains | Neutral |
| 06/02/2023 | 139.62% | Goldman Sachs | $2.75 → $0.75 | Downgrades | Buy → Neutral |
| 05/15/2023 | 858.47% | BTIG | $5 → $3 | Maintains | Buy |
| 05/01/2023 | 858.47% | Goldman Sachs | $3.5 → $3 | Maintains | Buy |
| 03/16/2023 | 1497.44% | BTIG | → $5 | Maintains | Buy |
| 11/14/2022 | 2136.42% | Cowen & Co. | $9 → $7 | Maintains | Outperform |
| 11/09/2022 | 2136.42% | BTIG | → $7 | Maintains | Buy |
| 10/21/2022 | 1816.93% | Goldman Sachs | $7 → $6 | Maintains | Buy |
| 08/12/2022 | 2775.4% | BTIG | $11 → $9 | Maintains | Buy |
| 08/11/2022 | 2455.91% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight |
| 05/12/2022 | 3094.89% | Morgan Stanley | $11 → $10 | Maintains | Equal-Weight |
| 03/30/2022 | 3414.38% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 10/19/2021 | 3733.87% | Morgan Stanley | → $12 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 5970.29% | Goldman Sachs | → $19 | Initiates Coverage On | → Buy |
| 10/19/2021 | 4372.84% | Cowen & Co. | → $14 | Initiates Coverage On | → Outperform |
| 01/03/2019 | — | Benchmark | Upgrades | Hold → Speculative Buy | |
| 11/12/2018 | — | Benchmark | Downgrades | Speculative Buy → Hold |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/10/2023 | 59.74% | 高盛 | 0.75 美元 → 0.5 美元 | 维护 | 中立 |
| 06/05/2023 | 139.62% | 高盛 | 2.75 美元 → 0.75 美元 | 维护 | 中立 |
| 06/02/2023 | 139.62% | 高盛 | 2.75 美元 → 0.75 美元 | 降级 | 买入 → 中性 |
| 05/15/2023 | 858.47% | BTIG | 5 美元 → 3 美元 | 维护 | 买 |
| 05/01/2023 | 858.47% | 高盛 | 3.5 美元 → 3 美元 | 维护 | 买 |
| 03/16/2023 | 1497.44% | BTIG | → 5 美元 | 维护 | 买 |
| 11/14/2022 | 2136.42% | Cowen & Co. | 9 美元 → 7 美元 | 维护 | 跑赢大盘 |
| 11/09/2022 | 2136.42% | BTIG | → 7 美元 | 维护 | 买 |
| 10/21/2022 | 1816.93% | 高盛 | 7 美元 → 6 美元 | 维护 | 买 |
| 2022 年 12 月 8 日 | 2775.4% | BTIG | 11 美元 → 9 美元 | 维护 | 买 |
| 08/11/2022 | 2455.91% | 摩根士丹利 | 10 美元 → 8 美元 | 维护 | 重量相等 |
| 05/12/2022 | 3094.89% | 摩根士丹利 | 11 美元 → 10 美元 | 维护 | 重量相等 |
| 03/30/2022 | 3414.38% | 摩根士丹利 | 12 美元 → 11 美元 | 维护 | 重量相等 |
| 10/19/2021 | 3733.87% | 摩根士丹利 | → 12 美元 | 启动覆盖范围开启 | → 重量相等 |
| 10/19/2021 | 5970.29% | 高盛 | → 19 美元 | 启动覆盖范围开启 | → 购买 |
| 10/19/2021 | 4372.84% | Cowen & Co. | → 14 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 01/03/2019 | — | 基准 | 升级 | 持有 → 投机性买入 | |
| 11/12/2018 | — | 基准 | 降级 | 投机性买入 → 持有 |
What is the target price for Cue Health (HLTH)?
Cue Health（HLTH）的目标价格是多少？
The latest price target for Cue Health (NASDAQ: HLTH) was reported by Goldman Sachs on November 10, 2023. The analyst firm set a price target for $0.50 expecting HLTH to rise to within 12 months (a possible 59.74% upside). 7 analyst firms have reported ratings in the last year.
高盛于2023年11月10日公布了Cue Health（纳斯达克股票代码：HLTH）的最新目标股价。该分析公司将目标股价定为0.50美元，预计HLTH将在12个月内升至12个月内（可能上涨59.74％）。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Cue Health (HLTH)?
分析师对Cue Health（HLTH）的最新评级是多少？
The latest analyst rating for Cue Health (NASDAQ: HLTH) was provided by Goldman Sachs, and Cue Health maintained their neutral rating.
Cue Health（纳斯达克股票代码：HLTH）的最新分析师评级由高盛提供，Cue Health维持中性评级。
When is the next analyst rating going to be posted or updated for Cue Health (HLTH)?
Cue Health（HLTH）的下一次分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cue Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cue Health was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Cue Health的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Cue Health的最新评级是在2023年11月10日发布的，因此您应该预计下一个评级将在2024年11月10日左右公布。
Is the Analyst Rating Cue Health (HLTH) correct?
分析师评级提示生命值（HLTH）是否正确？
While ratings are subjective and will change, the latest Cue Health (HLTH) rating was a maintained with a price target of $0.75 to $0.50. The current price Cue Health (HLTH) is trading at is $0.31, which is out of the analyst's predicted range.
虽然评级是主观的，而且会发生变化，但最新的Cue Health（HLTH）评级保持不变，目标价为0.75美元至0.50美元。Cue Health（HLTH）目前的交易价格为0.31美元，超出了分析师的预期区间。